| Lonza | 79.97 |
| Date/Time | 10/21 / 00:00 |
| Chg. / Chg.(%) | - / |
| Bid | 79.90 |
| Ask | - |
| Open | 79.97 |
| Previous Close | - |
| High | 79.97 |
| Low | 79.97 |
| Volume [SGD] | - |
| Volume [Units] | 500 |
| Price fixings | |
| ISIN | CH0013841017 |
| Security | O6Z |
| Exchange | Singapore |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| SIX Swiss Ex.. | 338.60 |  |
204,011 |
| London Inter.. | 338.70 | |
1,585 |
| Lang & Schwa.. | 309.200 | |
|
| Nasdaq Other.. | 344.7686 | |
82 |
| Cboe Europe .. | 328.30 | 47,868 | |
| Turquoise | 328.30 |  |
18,782 |
| Cboe Europe .. | 328.00 | 12,923 | |
| TradeGate | 294.000 | 298 | |
| Stuttgart | 294.000 | 135 | |
| Frankfurt | 293.9000 | 63 | |
| Düsseldorf | 291.20 | 0 | |
| München | 291.30 | 0 | |
| Berlin | 296.90 | 0 | |
| Hamburg | 291.30 | 0 | |
| gettex | 296.100 | ||
| Singapore | 79.97 | 500 | |
| EUREX | Options | ||
News
- Todos and Amarantus JV Announces Full Enrollment for Clinical Trial of LymPro Alzheimer’s Blood Test Relationship with Amyloid PET
11/14/2019 / 17:02 - GlobeNewswire - Vaxart Announces Third Quarter 2019 Financial Results and Provides Corporate Update
11/12/2019 / 22:45 - GlobeNewswire - Prevail Therapeutics Reports Third Quarter 2019 Financial Results and Recent Business Highlights
11/12/2019 / 15:30 - GlobeNewswire - Vaxart Hosting Key Opinion Leader Meeting on the Health Economics of Norovirus Disease
11/06/2019 / 14:00 - GlobeNewswire - Global Primary Cells Market Analysis, Trends, and Forecasts Report 2019
10/30/2019 / 11:17 - GlobeNewswire
Real-time